Kirjaudu sisään Inderes Free -tilillesi nähdäksesi kaikki sivun maksuton sisältö.

Luo ilmainen tunnus

I-tech

50,20 SEK

+5,46 %

Alle 1K seuraajaa

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Yleiskuva

Luvut & ennusteet

Omistajat

Osinko

Sijoittajakonsensus

+5,46 %

+13,83 %

−3,83 %

−8,39 %

−47,27 %

−38,40 %

−31,04 %

−32,16 %

+103,53 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Markkina-arvo

602,29 milj. SEK

Vaihto

1,6 milj. SEK

Liikevaihto

EBIT %

P/E -luku

Osinkotuotto %

Liikevaihto ja EBIT-%

Liikevaihto milj.

EBIT-% (oik.)

EPS ja Osinko

EPS (oik.)

Osinko %

Pörssikalenteri

7.5.

2026

Osavuosikatsaus Q1'26

21.8.

2026

Osavuosikatsaus Q2'26

16.10.

2026

Osavuosikatsaus Q3'26

Kaikki

Tiedotteet

Kolmansien osapuolien sisällöt

NäytäKaikki sisältötyypit

Lehdistötiedote9.2.2026 klo 9.46

Redeye: I-Tech (Q4 Review): Short-term volatility persists, long-term case intact

Kolmannen osapuolen analyysi6.2.2026 klo 6.20

I-tech: A pause in pace, not the story - ABG

* Q4: -23% organic growth (vs. ABGSCe -12%) * Financially constrained customer weighed on ’25 org. growth * Long-term potential intact, expect continued CMP growth in '26e 2025, a mixed financial year Q4 organic growth came in below our estimate at -...

Lehdistötiedote5.2.2026 klo 10.20

Correction: Time for live year-end report presentation

Liity Inderesin yhteisöön

Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.

FREE-tili

Pörssin suosituin aamukatsaus

Analyytikon kommentit ja suositukset

Osakevertailu

PREMIUM-tili

Kaikki yhtiöraportit ja sisällöt

Premium-työkalut (mm. sisäpiirin kaupat ja screeneri)

Mallisalkku

Luo ilmainen tunnus

Kolmannen osapuolen analyysi5.2.2026 klo 10.06

I-tech: Customer pullback weighing on growth - ABG

Sales -13% vs. ABGSCe, EBIT SEK 7.6m vs. ABGSCe 9.4m * Three coating products launched in Korea in Q4 * Sizeable customer with financial constraints impacting volumes Q4 results I-Tech reported sales of SEK 39m, falling 13% short of our estimate (-33...

Pörssitiedote5.2.2026 klo 7.00

I-Tech AB (publ) (ticker: ITECH) publish the year-end report for 2025

Kolmannen osapuolen analyysi29.1.2026 klo 8.48

I-tech: No easy lap into Q4e - ABG

* Q4e sales SEK 45m (58m), adj. EBIT SEK 10m (19m) * We cut '26e-'27e sales and EBIT by 10% and 22-19%, respectively * Lowered growth assumptions for CMP Tough comps in Q4e We estimate Q4 sales of SEK 45m, -23% y-o-y (-12% organic, -11% FX). I-Tech is...

Pörssitiedote17.12.2025 klo 15.30

Raouf Kattan resigns as a board member of I-Tech AB (publ)

Kolmannen osapuolen analyysi27.11.2025 klo 9.39

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

Pörssitiedote27.11.2025 klo 7.45

I-Tech strongly rejects the European Commission’s proposed non-renewal of Medetomidine under the EU Biocidal Products Regulation (BPR)

Lehdistötiedote24.11.2025 klo 9.00

I-Tech and Havey sign MoU to collaborate on the development of next-generation antifouling materials

Lehdistötiedote18.11.2025 klo 9.00

I-Tech's Nomination Committee appointed

Lehdistötiedote21.10.2025 klo 8.25

Redeye: I-Tech (Q3 Review) - Forecasts Trimmed, Long-Term View Unchanged

Kolmannen osapuolen analyysi20.10.2025 klo 7.17

I-tech: Customer slowdown tempers growth - ABG

* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than ...

Kolmannen osapuolen analyysi17.10.2025 klo 7.05

I-tech: Q3 impacted by weaker market conditions - ABG

Sales -18% vs. ABGSCe, EBIT SEK 11m vs. ABGSCe 16m* Newbuild market down 50% y-o-y, affecting growth* Sizeable customer has reduced planned volumes for '25Q3 resultsQ3 sales came in lower than expected at SEK 41m (-18% vs. ABGSCe 50m). The company writes...

Pörssitiedote17.10.2025 klo 6.00

I-Tech AB (publ) (ticker: ITECH) publish the interim report for the third quarter 2025

Kolmannen osapuolen analyysi7.10.2025 klo 7.09

I-tech: Sales recovery expected in Q3 - ABG

* Report out on 17 October* Q3e sales of SEK 50m, +23% y-o-y, EBIT SEK 16m (9m)* Q3 rebound expected after Q2 dip Q3 expectations We estimate Q3 sales of SEK 50m, +23% y-o-y (+35% organic, -12% FX). We expect Q3 to demonstrate that Q2 was a temporary...

Lehdistötiedote25.8.2025 klo 9.24

Redeye: I-Tech - Q2 Review – Temporary Slowdown

Kolmannen osapuolen analyysi25.8.2025 klo 5.28

I-tech: A pause, not a stop - ABG

* Weaker Q2 due to natural quarterly variations* Cut '25e-'27e EBIT by 12-13%* Demand intact, rebound expected in Q3Growth halted, but we expect a rebound in Q3I-Tech reported weaker Q2 sales of SEK 32m (-39% vs. ABGSCe, -26% y-o-y) and EBIT of SEK 5m...

Kolmannen osapuolen analyysi22.8.2025 klo 7.42

I-tech: Big Q2 miss halts sales growth - ABG

* Sales -39% vs. ABGSCe, EBIT SEK 5m vs. ABGSCe 16m * Weak Q2 due to inventory build-up following strong Q4/Q1* Gross margin continues to improve (59% vs. ABGSCe 56%) Weaker Q2 than expected Sales came in lower than expected at SEK 32m (-39% vs. ABGSCe...

Pörssitiedote22.8.2025 klo 6.00

I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2025

Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.